Authors: Mary Dale Peterson, MD, MHA, FACHE, FASA; Mike Schweitzer, MD, MBA ASA Monitor December 2022, Vol. 86, 1–5. Amid the ongoing COVID-19 pandemic, hospital and health system executives face enormous financial pressures. Labor costs are up across the board, including for anesthesia services, and anesthesiologists must recognize that hospital and health system executives typically view the […]
Read MoreAuthors: George Williams, MD, FASA, FCCM, FCCP; Erin Scott Williams, MD, FAAP ASA Monitor December 2022, Vol. 86, 23. The past year, and furthermore, the past several years, have been quite interesting and eventful to be sure. A torrent of troubling news pertinent to every demographic, social class, community, and profession has become part of the daily […]
Read MoreAuthors: Brittany N. Burton, M.D., M.H.S., M.A.S. et al Anesthesiology January 2023, Vol. 138, 116–117. To the Editor: We have read the study titled “Personalized Surgical Transfusion Risk Prediction Using Machine Learning to Guide Preoperative Type and Screen Orders” by Lou et al.1 and the accompanying editorial titled “Moving from ‘Surgeries’ to Patients: Progress and Pitfalls While Using […]
Read MoreAutors: Matthew A. C. Zapf, M.D. et al Anesthesiology January 2023, Vol. 138, 117–118. To the Editor: We have read with great interest the recent article by Lou et al., in which they used the American College of Surgeons National Surgical Quality Improvement Program participant use data file to expertly develop a transfusion prediction model with the goal […]
Read MoreAuthors: Sunny S. Lou, M.D., Ph.D. et al In Reply: We thank Burton et al. and Zapf et al. for their thoughtful comments on our research on personalized surgical transfusion risk prediction. Both letters raise important considerations regarding variable selection for predictive models in health care, which are worth discussing in further detail. As Burton et al. note, race and ethnicity […]
Read MoreASA Monitor December 2022, Vol. 86, 15–16. Trends Two type 2 diabetes medications outperformed others in NIH-funded clinical trial In a large clinical trial comparing four drug medications approved by the U.S. Food and Drug Administration for the treatment of type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best to maintain blood […]
Read MoreAuthor: Allen N. Gustin, Jr., MD, FCCP, FASA, FCCM ASA Monitor December 2022, Vol. 86, 22. What is gratitude? Webster’s Dictionary defines gratitude as the following: the quality of being thankful, ready to show appreciation (asamonitor.pub/3SPtiAL). How did gratitude end up in my practice as a physician? How has gratitude helped me cope with the daily challenges of […]
Read MoreAuthors: Jamie R. Privratsky, MD/PhD et al Anesthesiology November 2022. Background Acute kidney injury (AKI) following non-cardiac surgery is common and has substantial health impact. Preclinical and clinical studies examining the influence of sex on AKI have yielded conflicting results, although they typically do not account for age-related changes. The objective of our study was […]
Read MoreAuthors: Brian M. Ilfeld, M.D., M.S. et al Anesthesiology January 2023, Vol. 138, 82–97. Background Postamputation phantom pain is notoriously persistent with few validated treatments. Cryoneurolysis involves the application of low temperatures to reversibly ablate peripheral nerves. The authors tested the hypothesis that a single cryoneurolysis treatment would decrease phantom pain 4 months later. Methods The […]
Read MoreAuthor: Mariah Taylor Becker’s Hospital Review A recent study found that delaying surgery after a COVID-19 infection reduced the risk of major postoperative heart events. The study, published in JAMA Network Open, followed 3997 patients who had surgery after a COVID-19 infection. Patients underwent surgery anywhere from 30 days to 225 days, with a median time of 98 days […]
Read More